Cargando…
Protective barrier properties of Rhinosectan(®) spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study
BACKGROUND: To evaluate barrier protective properties of Rhinosectan(®) spray, a medical device containing xyloglucan, on nasal epithelial cells (MucilAir). METHODS: MucilAir-Nasal, a three-dimensional organotypic (with different cell types) airway tissue model, was treated with the medical device R...
Autores principales: | De Servi, Barbara, Ranzini, Francesco, Piqué, Núria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553660/ https://www.ncbi.nlm.nih.gov/pubmed/28811823 http://dx.doi.org/10.1186/s13223-017-0209-6 |
Ejemplares similares
-
Rhinosectan(®) spray (containing xyloglucan) on the ciliary function of the nasal respiratory epithelium; results of an in vitro study
por: Piqué, Núria, et al.
Publicado: (2018) -
Combining MucilAir™ and Vitrocell(®) Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen
por: Metz, Julia, et al.
Publicado: (2018) -
The Biological Effects of Complete Gasoline Engine Emissions Exposure in a 3D Human Airway Model (MucilAir(TM)) and in Human Bronchial Epithelial Cells (BEAS-2B)
por: Rossner, Pavel, et al.
Publicado: (2019) -
Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview
por: Piqué, Núria, et al.
Publicado: (2018) -
Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical Trial
por: Pleșea Condratovici, Cătălin, et al.
Publicado: (2016)